{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:34:09Z","timestamp":1782401649966,"version":"3.54.5"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00055","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:16:45Z","timestamp":1548908205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":268,"title":["Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis"],"prefix":"10.3389","volume":"10","author":[{"given":"Eleni","family":"Karakike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004 diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","article-title":"Secondary hemophagocytic lymphohistocytosis and severe sepsis\/systemic inflammatory response\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation","volume":"10","author":"Carcillo","year":"2009","journal-title":"Pediatr Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002318","article-title":"Hemophagocytic lymphohistiocytosis in intensive care unit","author":"Barba","year":"2015","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bjh.13837","article-title":"Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years","volume":"172","author":"Schram","year":"2016","journal-title":"Br J Haematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.semarthrit.2015.10.015","article-title":"Macrophage activation syndrome: A severe and frequent manifestation of acute pancreatitis in 362 childhood-onset compared to 1830 adult-onset systemic lupus erythematosus patients","volume":"45","author":"Gormezano","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jceh.2017.01.119","article-title":"Hemophagocytic lymphohistiocytosis masquerading as acute liver failure: a single center experience","volume":"7","author":"Japtag","year":"2017","journal-title":"J Clin Exp Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-017-3625-6","article-title":"Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China","volume":"37","author":"Liu","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","article-title":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza","volume":"213","author":"Schulert","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","article-title":"Macrophage activation syndrome in adults, recent advances in pathophysiology, diagnosis and treatment","volume":"58","author":"Carter","year":"2018","journal-title":"Rheumatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","article-title":"Successful treatment of severe paedriatric rheumatic disease-associated macrophage activation syndrome with interleukin 1-inhibition following conventional immunosuppressive therapy: case series with 12 patients","volume":"50","author":"Miettunen","year":"2011","journal-title":"Rheumatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis \/sepsis \/multiple organ dysfunction \/ macrophage activating syndrome in critically ill children","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.4049\/jimmunol.1501035","article-title":"Mouse cytomegalovirus infection in BALB\/c mice resembles virus-associated hemophagocytic lymphohistiocytosis and shows a pathogenesis distinct from primary hemophagocytic lymphohistiocytosis","volume":"96","author":"Brisse","year":"2016","journal-title":"J Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc'h","year":"2018","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"574","DOI":"10.14423\/SMJ.0000000000000339","article-title":"Etiologies and short-term mortality in patients with ultraelevated serum ferritin","volume":"108","author":"Beer","year":"2015","journal-title":"South Med J."},{"key":"B23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/cei.13057","article-title":"H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome","volume":"191","author":"Ruscitti","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.cyto.2018.05.017","article-title":"Soluble CD16, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis","volume":"110","author":"Sakamura","year":"2018","journal-title":"Cytokine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD, a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/PCC.0000000000001507","article-title":"Hypofibrinogenemia is associated with poor outcome and secondary hemophagocytic lymphohistiocytosis\/macrophage activation syndrome in pediatric severe sepsis","volume":"19","author":"Signoff","year":"2018","journal-title":"Pediatr Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007901","article-title":"The clinical utility of splenic fluorodeoxyglucose uptake for diagnosis and prognosis in patients with macrophage activation syndrome","author":"Ahn","year":"2017","journal-title":"Medicine"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial","volume":"25","author":"Opal","year":"1997","journal-title":"Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","article-title":"Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis","volume":"15","author":"Kyriazopoulou","year":"2017","journal-title":"BMC Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001265.","article-title":"Late peaks of HMGB1 and sepsis outcome: evidence for synergy with chronic inflammatory disorders","author":"Karakike","year":"2018","journal-title":"Shock"},{"key":"B32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2119\/molmed.2014.00183","article-title":"High systemic levels of the cytokine inducing HMGB1 isoform secreted in severe macrophage activation syndrome","volume":"20","author":"Palmblad","year":"2014","journal-title":"Mol Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/PCC.0000000000001029","article-title":"A systemic inflammation mortality risk assessment contingency table for severe sepsis","volume":"18","author":"Carcillo","year":"2017","journal-title":"Pediatr Crit Care Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/cc10073","article-title":"Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection","author":"Beutel","year":"2011","journal-title":"Crit Care"},{"key":"B37","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s10875-017-0439-x","article-title":"A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults","volume":"37","author":"Kumar","year":"2017","journal-title":"J Clin Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1097\/PCC.0000000000000896","article-title":"High-volume hemofiltration in critically ill patients with secondary hemophagocytic lymphohistiocytosis\/macrophage activation syndrome: a prospective study in the PICU","volume":"17","author":"Cui","year":"2016","journal-title":"Pediatr Crit Care Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00055\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T04:16:46Z","timestamp":1548908206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00055\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2019.00055"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00055","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"article-number":"55"}}